SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-21-006644
Filing Date
2021-06-17
Accepted
2021-06-17 06:30:21
Documents
15
Period of Report
2021-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 s6162108k.htm 8-K 21873
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 19123
3 GRAPHIC slide_001.jpg GRAPHIC 186776
4 GRAPHIC slide_002.jpg GRAPHIC 409353
5 GRAPHIC slide_003.jpg GRAPHIC 285719
6 GRAPHIC slide_004.jpg GRAPHIC 411616
7 GRAPHIC slide_005.jpg GRAPHIC 271119
8 GRAPHIC slide_006.jpg GRAPHIC 221227
9 GRAPHIC slide_007.jpg GRAPHIC 329957
10 GRAPHIC slide_008.jpg GRAPHIC 191792
11 GRAPHIC slide_009.jpg GRAPHIC 219191
12 GRAPHIC slide_010.jpg GRAPHIC 295542
13 GRAPHIC slide_011.jpg GRAPHIC 122203
14 GRAPHIC slide_012.jpg GRAPHIC 186515
15 GRAPHIC slide_013.jpg GRAPHIC 233413
  Complete submission text file 0001214659-21-006644.txt   4677692
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 211023337
SIC: 2834 Pharmaceutical Preparations